Quipt Home Medical Reports Revenue and Earnings Miss
Quipt Home Medical Corp. (NASDAQ:QIPT) reported a loss for the period ending December 15, 2025, with an earnings per share of -$0.08. This result fell below the analyst estimate of $0.03. The company recorded revenue of $68.3 million, which was also lower than the projected $105 million.
Despite the financial miss, the stock price increased 34.1%, opening at $3.50 on December 16, 2025. This price action followed a surge in options trading, where investors purchased 5,781 call options compared to the daily average of 418. The company currently maintains a market capitalization of $152 million and a beta of 0.59.
Financial liquidity metrics show a quick ratio of 0.75 and a current ratio of 1.15. The debt-to-equity ratio stands at 0.71, while the price-to-earnings ratio is -14.75 with an earnings yield of -6.78%. Additional valuation metrics include a price-to-sales ratio of 0.61 and an enterprise value to operating cash flow ratio of 6.73.
Quipt Home Medical Corp. provides in-home monitoring and disease management services for patients with chronic conditions. For more information on the company, see the QIPT and the QIPT. Detailed analysis is available in the QIPT and the QIPT.
Quipt Home Medical Corp. (QIPT) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.